Target intelligence / Profile preview

Transient receptor potential ankyrin 1 and transient receptor potential vanilloid 1 (TRPA1/TRPV1)

Target
TRPA1/TRPV1
Molecular classification
Ion channel, Transient receptor potential channel, Receptor
01

Overview

Transient receptor potential ankyrin 1 (TRPA1) and transient receptor potential vanilloid 1 (TRPV1) are non-selective cation channels primarily expressed in nociceptive sensory neurons (Julius, 2013). They serve as polymodal sensors for noxious heat (TRPV1), cold (TRPA1), and various chemical irritants, and are known to be co-expressed and form functional heteromeric complexes (Starowicz et al., 2008; Akopian, 2011). These channels play a significant role in chronic pain, neurogenic inflammation, and respiratory conditions like asthma and chronic cough (Nilius & Szallasi, 2014). Therapeutic targeting of these channels, particularly through antagonism, aims to alleviate pain and inflammation, though clinical progress for TRPV1 antagonists has been hindered by side effects such as hyperthermia (Gavva et al., 2008). The interaction between TRPA1 and TRPV1 suggests that dual antagonism or targeting the heteromeric complex may offer enhanced therapeutic efficacy in certain disease states.

Other names
TRPA1-TRPV1 complexTRPA1/V1ANKTM1/VR1Transient receptor potential cation channel subfamily A member 1 and transient receptor potential cation channel subfamily V member 1
02

Mechanism of action

Antagonism of TRPA1 and TRPV1 ion channels to inhibit the influx of cations (Ca2+, Na+), thereby reducing neuronal excitability and pain signaling (Julius, 2013; Nilius & Szallasi, 2014).

03

Biological functions

NociceptionThermosensationChemosensationSignal transductionInflammatory response
04

Disease associations

Chronic painNeuropathic painInflammationAsthmaChronic coughOsteoarthritis
05

Safety considerations

HyperthermiaImpaired noxious heat sensationRespiratory irritationRisk of thermal injury
06

Interacting drugs

Capsaicin

6 more in the full profile.

07

Biomarkers

TRPV1 expression levelsTRPA1 expression levelsCapsaicin-induced dermal flare responseCapsaicin-induced cough frequency

Beyond the preview

Go deeper on Transient receptor potential ankyrin 1 and transient receptor potential vanilloid 1 (TRPA1/TRPV1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transient receptor potential ankyrin 1 and transient receptor potential vanilloid 1 (TRPA1/TRPV1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call